I promised to share when info came out... - Lung Cancer Support

Lung Cancer Support

4,050 members2,201 posts

I promised to share when info came out. It's good news.

Denzie profile image
DenzieModeratorVolunteer
4 Replies

Some of you know that I am in the second part of this Exceptional Responders study. There's some good and interesting news out of the first cohort.

"The findings from a recent study of patients with cancer who had an exceptional response to chemotherapy are yielding new clues on the molecular changes in patients’ tumors. These findings may explain the genetic alterations contributing to these patients’ dramatic and long-lasting responses to treatment—and could lead to achieving personalized treatment for more patients."

ascopost.com/issues/april-1...

Written by
Denzie profile image
Denzie
Moderator
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Swimdown profile image
Swimdown

Thanks Denzie🌈

etpd2226 profile image
etpd2226

Awesome news!!! Thx for sharing.

Dariada profile image
Dariada

Thanks for sharing this information!

Kaylee20 profile image
Kaylee20

It's so good to hear good news for a change when sometimes all we get is bad news. Thanks for sharing Denzie

Not what you're looking for?

You may also like...

9 years today

Hi all. It’s been 9 years since I learned my preliminary diagnosis of lung cancer. Later I would...

What It's Like to Be in a Lung Cancer Clinical Trial - Part One, Background Information

Have you ever thought about participating in a lung cancer clinical trial? The thought of taking an...

An immunotherapy now approved for first-line treatment

Late yesterday, the FDA approved Keytruda (an immunotherapy) as a first-line treatment for patients...

My Story

In 10/2010 I was diagnosed with stage 4 poorly differentiated adenocarcinoma of the lung. The dr...

First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)

On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...